"Itraconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
| Descriptor ID |
D017964
|
| MeSH Number(s) |
D03.383.129.799.550 D03.383.606.530
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Itraconazole".
Below are MeSH descriptors whose meaning is more specific than "Itraconazole".
This graph shows the total number of publications written about "Itraconazole" by people in this website by year, and whether "Itraconazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 0 | 2 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 3 | 3 |
| 2019 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Itraconazole" by people in Profiles.
-
Laryngeal histoplasmosis in a kidney transplant recipient. Transpl Infect Dis. 2019 Aug; 21(4):e13102.
-
A 15-year-old boy with severe combined immunodeficiency, fungal infection, and weight gain. Allergy Asthma Proc. 2015 Sep-Oct; 36(5):407-11.
-
Ulcerated plaque under a ruby ring in an immunosuppressed patient. Dermatol Online J. 2010 Aug 15; 16(8):4.
-
Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome. Support Care Cancer. 2011 Jan; 19(1):19-26.
-
Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies. Antimicrob Agents Chemother. 2006 Jan; 50(1):143-7.
-
Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis. Cancer. 2005 Jun 01; 103(11):2334-7.
-
Cholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors. Antimicrob Agents Chemother. 2005 Feb; 49(2):518-24.
-
Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy. Cancer. 2004 Feb 01; 100(3):568-73.
-
Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy. Medicine (Baltimore). 2003 Sep; 82(5):309-21.
-
[Genital histoplasmosis. Presentation of a clinical case]. Arch Esp Urol. 2003 Jun; 56(5):462-6.